<DOC>
	<DOCNO>NCT02338427</DOCNO>
	<brief_summary>Amyloidosis involve many rare disease relation diversity amyloid proteins involve formation abnormal tissue deposit . There approximately 30 protein involve amylose 's constitution . The therapeutic management varies depend type amyloidosis observe . The application conventional technique immunolabeling amylose allow comprehensive characterization amylose form , due failure technic , false positivity result , lack frozen tissue available type light chain ( lambda , kappa ) . In study , main objective comparison two capacity amylose characterisation : immunohistochemistry proteomics analysis . The purpose study validate superiority proteomic analysis demonstrate improvement precision , reduction technical failure , well correction erroneous diagnosis , authorize adapt therapeutic management .</brief_summary>
	<brief_title>Capacity Amylose Characterisation Compare Immunohistochemistry Proteomic Analysis</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Upper age 18 year Amylose diagnosis establish tissue sample , `` Rouge Congo '' coloration All patient amylose identify two laboratory anatomopathology Sample necessary realize proteomic analysis No opposition participation study Patient sign inform consent biology collection Tissue sample inadequate apply immunohistochemistry proteomic identification Patient trust , guardianship , legal protection measure , deprive freedom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>